52152-93-9NC(=O)c1cc[n+](CC2=C(C(=O)[O-])N3C(=O)[C@@H](NC(=O)[C@@H](c4ccccc4)S(=O)(=O)[O-])[C@H]3SC2)cc1.[Na+]REACMANCWHKJSM-DWBVFMGKSA-MCefsulodin sodium is an organic molecular entity.
52152-93-9CHEMBL1256939、CHEMBL1590946CHEBI:31380Safety information is for reference only and does not replace the supplier’s Safety Data Sheet (SDS), applicable regulations, or professional assessment.
Danger
H315 (96.2%): Causes skin irritation [Warning Skin corrosion/irritation]
P233, P260, P261, P264, P264+P265, P271, P272, P280, P284, P302+P352, P304+P340, P305+P351+P338, P319, P321, P332+P317, P333+P317, P337+P317, P342+P316, P362+P364, P403, P403+P233, P405, and P501 (click each P-code to see the statement)
Aggregated GHS information provided per 53 reports by companies from 11 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.
Chemical: Pyridinium, 4-(aminocarbonyl)-1-[[2-carboxy-8-oxo-7-[(phenylsulfoacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-en-3-yl]methyl]-, hydroxide, inner salt, monosodium salt, [6R-[6.alpha.,7.beta.(R*)]]-
PMN - indicates a commenced PMN (Pre-Manufacture Notices) substance.
Cefsulodine sodium: Does not have an individual approval but may be used as a component in a product covered by a group standard. It is not approved for use as a chemical in its own right.
DescriptionCefsulodin was synthesized by Takeda Chemicals Industries in 1974 by introducing the sulfobenzyl group, the same moiety as in sulbenicillin, at the 7 position of the cephem nucleus. Its side chain at the 3 position is similar to that of cephaloridine except for the carbamoyl group. The introduction of these hydrophilic groups increases the activity against Pseudomonas aeruginosa, but it markedly decreases it against gram-positive and other gramnegative bacteria. Therefore cefsulodin is used as a specific antibiotic against infections caused by the opportunistic pathogen P. aeruginosa.
UsesCefsulodin is most commonly used in CIN agar to select for Yersinia microorganisms. The compound displays a mechanism of action like many β lactam antibiotics through inhibition of cell wall synthesis by competitively inhibiting penicillin binding protein (PBP) crosslinking of peptidoglycan resulting in inhibition of the final transpeptidation step. Through the inability for Cefsulodin sodium salt hydrate to inhibit cefsulodin-resistant mutants of Pseudomonas aeruginosa PAO4089 growth displayed that Cefsulodin sodium salt hydrate may compete with PBP3 in addition to PBP1A and PBP1B.
Usesbetaadrenergic blocker
UsesCefsulodin is a third generation cephalosporin (C258750) antibiotic designed specifically for Pseudomonas Aeruginosa.
UsesA β lactam antibiotic.
No reaction records under the current filter.
Loading…
PreparationRecrystallization of cefsulodin free acid from dimethylformamide: 1. Weigh 10.0 g of cefsulodin free acid powder into a 500 mL flask. Store the cefsulodin free acid powder in a refrigerator and warm it to room temperature before use. 2. At room temperature, add 25 mL of DMF to the flask with vigorous stirring to provide a clear solution. 3. Stop stirring, cool the solution, and store it overnight at 4°C to provide cefsulodin free acid crystals. Collect the cefsulodin free acid crystals by vacuum filtration. Wash the crystals with water (2×30 mL), ethanol (2×30 mL), and ether (30 mL). 4. Then dry the crystals on P2O5 under a higher vacuum. 5. The purity of the final product was determined using HPLC. 6. The yield was 80-85%.
DefinitionChEBI: Cefsulodin sodium is an organic molecular entity.